Euclid Systems
VA - SterlingBiotechnology
Focus: Euclid Systems specializes in corneal reshaping contact lenses for myopia correction, operating in the ophthalmology segment since 1995. The company focuses on a niche medical device market with a specific therapeutic application.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Open Jobs
0
About Euclid Systems
AI assessmentNot HiringNo open roles listed right now. Follow Euclid Systems to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Euclid orthokeratology MAX
MyopiaClinical Trials (1)
NCT06389916Euclid Phoenix Lens Design Trial
N/AHelp build intelligence for Euclid Systems
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.